£2.0M
The seed round was co-led by Shilling and Plus Partners to accelerate commercial expansion across the UK and Spain.
"Dementia is never just one person’s disease. It affects entire families, and carers often carry an enormous invisible burden."
Portfolio
2
companies
Investment by month
By category
- AI/ML£2.0M
- Uncategorised£883K
By location
- London£2.0M
- Porto£883K
Portfolio companies
Punto Health
Punto Health develops an artificial intelligence powered platform for dementia and cognitive care.
R
Reviewpad
Reviewpad builds an artificial intelligence platform that automates software code reviews.
Team
Tomás Güida
Investment Manager
Tomás brings investment and founding experience from venture capital firms and an education startup. He currently serves as Principal at Shilling VC.
LinkedIn
Pedro Carlos
Partner at Shilling VC
Pedro serves as a partner at Shilling and Shilling Founders Fund, alongside managing partner roles at Springpoint and Springbreak. He also holds board positions at Brandgest.
LinkedIn
Pedro Ramalho Carlos
Partner
Pedro is a partner at Shilling and Shilling Founders Fund, alongside managing partner roles at Springpoint and Springbreak. He also serves on the board of directors at Brandgest.
Recent investments
€1.0M
The pre seed round was led by Shilling with backing from angel investors Simon Brandhof and Freddy Mallet.
"We believe that this innovative, ambitious, and technical product can be accomplished by Reviewpad because the founders combine vision and experience. We’re excited to see how they will leverage their specific technologies and AI to make the CI/CD software development process even faster, more reliable, and higher quality for agile teams globally"